Theratechnologies & Canadian Gene Cure Foundation create the A. Jean de Grandpré MD/PhD Scholarship in support of Genetic Research in Canada

Montreal, November 27, 2001 - Theratechnologies of Montreal, Quebec and the Canadian Gene Cure Foundation today announced the creation of a scholarship in the name of A. Jean de Grandpré, to be awarded to a student in McGill University's combined MD/PhD training program. Theratechnologies is providing $30,000 in support of the scholarship and as a contribution to Jeans for Genes Day™, the annual fund raising campaign of the Canadian Gene Cure Foundation (CGCF), held across Canada each November in support of human genetic disease research.

The scholarship, which will be awarded in January 2002, is to be funded over a period of six years in the amount of $5,000 per year. The trustee of the scholarship is the Canadian Gene Cure Foundation.

Dr. André de Villers, Chief Executive Officer and Vice chairman of the Board of Theratechnologies, said "The A. Jean de Grandpré Scholarship will serve to underscore the importance of bridging business and science and will help nurture the entrepreneurial spirit of the leaders of tomorrow in the biopharmaceutical field." The award is named for Mr. de Grandpré, Chairman of the Theratechnologies Board since 1996. He is a prominent figure acknowledged for his significant contribution to business, his scientific curiosity, and his vision and dedication.

Said Dr. Ron Woznow, Chair of the CGCF Board, "Our annual Jeans for Genes campaign supports the development of the next generation of genetic researchers by raising funds for eight MD/PhD scholarships. We are delighted with Theratechnologies' decision to partner with us by creating the A. Jean de Grandpré Scholarship."

A leader in the biopharmaceutical field in Canada, Theratechnologies has developed an innovative therapeutic platform offering numerous applications in the field of therapeutic peptides. Through its subsidiary Celmed BioSciences, the Company also plays a key role in cell therapy based on the transplantation of adult stem cells.

The Canadian Gene Cure Foundation is a registered charity, established by the Canadian Genetic Diseases Network (CGDN) to raise funds for human genetic disease research in areas such as Alzheimer's disease, diabetes, brain, breast and ovarian cancers. The CGDN is a not-for-profit nation-wide center of research excellence under the federal Networks of Centres of Excellence Program. The Foundation shares a vision with CGDN and Canada's leading medical genetics researchers to work towards identifing the genes which contribute to inherited diseases and finding the cures.

The NCE Program is a federal initiative administered jointly through the Natural Sciences and Engineering Research Council (NSERC), the Canadian Institutes of Health Research (CIHR) and the Social Sciences and Humanities Research Council (SSHRC) in partnership with Industry Canada.